The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.18
Bid: 4.00
Ask: 4.32
Change: -0.39 (-8.57%)
Spread: 0.32 (8.00%)
Open: 4.32
High: 4.32
Low: 4.16
Prev. Close: 4.55
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

25 Jun 2020 07:00

RNS Number : 0036R
Plant Health Care PLC
25 June 2020
 

25 June 2020

Plant Health Care plc

("Plant Health Care" or the "Company")

Grant of options in Lieu of Cash bonus

Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce an options grant to two Executive Directors on 24 June 2020. In line with previous years, these Directors alongside other senior management of the Company have agreed to receive 50% of their potential 2020 bonus in the form of stock options (the "Bonus Scheme"). As part of the Bonus Scheme, options over a total of 853,659 ordinary shares of 1p each were granted to Jeffrey Tweedy and Jeffrey Hovey, Executive Directors of the Company. This is required to now be announced due to Jeffery Hovey and Jeffrey Tweedy being appointed to the Board on 1 November 2019.

The Company aims to reduce cash burn as much as possible to shorten the runway to cash break even, and the Bonus Scheme will help reduce the cash burn of the Company significantly over the next twelve months.

The options will be issued under the 2017 Employee Share Option Plan and were made in accordance with the terms of a share option agreement approved by the Company's Remuneration Committee, under which the options have an exercise price of £0.10, have a 10-year life and are subject to performance conditions. These awards will only vest if the Company achieves a certain financial result and if, in addition, specific annual objectives are met as a result the final awards under the Bonus Scheme to the Directors may be less.

Plant Health Care plc

Chris Richards - CEO

Jeffrey Hovey - Chief Financial Officer

 

+1 919 926 1600

 

Arden Partners plc

John Llewellyn-Lloyd / Dan Gee-Summons

+44 207 614 5900

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

Name

Mr Jeffrey Hovey

 

 

2.

Reason for the Notification

 

 

a)

Position/status

Chief Financial Officer

 

 

b)

Initial notification/ Amendment

Initial notification

 

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

Name

Plant Health Care plc

 

 

b)

LEI

213800KBQPJZ2FM8QH27

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

 

 

Identification code

GB00B01JC540

 

 

b)

Nature of the transaction

Grant of options

 

 

c)

Price(s) and volume(s)

Price

Volume

 

 

10.0p

325,203

 

 

d)

Aggregated information:

·Aggregated volume

·Price

 

325,203

As above

 

 

e)

Date of the transaction

24 June 2020

 

 

f)

Place of the transaction

Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mr Jeffrey Tweedy

2.

Reason for the Notification

a)

Position/status

Chief Operating Officer

b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Plant Health Care plc

b)

LEI

213800KBQPJZ2FM8QH27

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B01JC540

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Price

Volume

10.0p

528,455

d)

Aggregated information:

·Aggregated volume

·Price

 

528,455

As above

e)

Date of the transaction

24 June 2020

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSESFULESSEEM
Date   Source Headline
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.